This trial is testing the side effects of a combination of two drugs, one of which helps the body's immune system attack cancer cells, before surgery in patients with a type of cancer that can be removed surgically.
2 Primary · 3 Secondary · Reporting Duration: At time of surgery
14 Total Participants · 1 Treatment Group
Primary Treatment: Definitive Surgical Resection · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: